SEARCH

SEARCH BY CITATION

References

  • 1
    Schindhelm RK, Dekker JM, Nijpels G, Bouter LM, Stehouwer CDA, Heine RJ, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2007; 91: 391396.
  • 2
    Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007; 24: 16.
  • 3
    Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99S112.
  • 4
    Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fagà E, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease HEPATOLOGY 2005; 42: 11751183.
  • 5
    Gambino R, Cassader M, Pagano G, Durazzo M, Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? HEPATOLOGY 2007; 45: 10971107.
  • 6
    Qi L, Doria A, Manson JE, Meigs JB, Hunter D, Mantzoros CS, et al. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes 2006; 55: 15121516.
  • 7
    Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warran JH, Scherer PE, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance sindrome. Diabetes 2002; 51: 23062312.
  • 8
    Zacharova J, Chiasson JL, Laakso M, for the STOP-NIDDM Study Group. The common polymorphisms (single nucleotide polymorphism SNP +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes. The STOP-NIDDM Trial. Diabetes 2005; 54: 893899.
  • 9
    Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, Tiberti C, et al. The adiponectin gene SNP +276GT associates with early-onset coronary artery disease and lower levels of adiponectin in younger coronary artery disease (age ≤ 50 years). J Mol Med 2005; 83: 711719.
  • 10
    Lacquemant C, Froguel P, Lobbens S, Izzo P, Dina C, Ruiz J. The adiponectin gene SNP +45 is associated with coronary artery disease in type 2 (non insulin dependent) diabetes mellitus. Diabet Med 2004; 21: 776781.
  • 11
    Kang ES, Park SY, Kim HJ, Ahn CW, Nam M, Cha BS, et al. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care 2005; 28: 11391144.
  • 12
    Von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 2004; 27: 29252929.
  • 13
    Adiels M, Olofsson SO, Taskinen MR, Boren J. Diabetic dyslipidaemia. Curr Opin Lipidol 2006; 17: 238246.
  • 14
    Ravikumar B, Carey PE, Snaar JEM, Deelchand DK, Cook DB, Neely RDG, et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 2005; 288: E789E797.
  • 15
    Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 13431351.
  • 16
    Angulo P,. Hui JM, Marchesini G, Bugianesi E, George J,. Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. HEPATOLOGY 2007; 45: 846854.
  • 17
    Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 316.
  • 18
    Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 110.
  • 19
    Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict non-alcoholic fatty liver disease. Clin Chem 2007; 53: 686692.
  • 20
    Nunez C, Gallagher D, Visser M, Pi-Sunyer FX, Wang Z, Heynsfield SB. Bioimpedance analysis: evaluation of leg-to-leg system based on pressare contact footpad electrodes. Med Sci Sports Exerc 1997; 29: 524531.
  • 21
    Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 14621470.
  • 22
    Cassader M., Gambino R., Musso G, Depetris N, Mecca F, Cavallo-Perin P, et al. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids 2002; 36: 11171124.
  • 23
    Loos RJF, Ruchat S, Rankinen T, Tremblay A, Perusse L, Bouchard C. Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Quebec Family Study. Am J Clin Nutr 2007; 85: 2634.
  • 24
    Yang WS, Tsou PL, Lee WJ, Tseng DL, Chen CL, Peng CC, et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 2003; 81: 428434.
  • 25
    Soares A, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaidi-Tiali N, Lagarde M, et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3–L1 adipocytes. Free Radic Biol Med 2005; 38: 882889.
  • 26
    Paniagua JA, Gallego de la Sacristana A, Vidal-Puig A, Latre JM, Sanchez E, Perez-Martinez P, et al. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 2007; 30: 17171723.
  • 27
    Seo JB, Moon HM, Noh MJ, Lee YS, Jeong HW, Yoo EJ, et al. Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J Biol Chem 2004; 279: 2210822117.
  • 28
    Nagano K, Inoue N, Wang YM, Yanagita T. Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in diabetic (fa/fa) rats. Biochem Biophys Res Common 2003; 310: 562566.
  • 29
    Ide T. Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes 2005; 54: 412423.
  • 30
    Mostad IL, Qvistad E, Bjerve KS, Grill VE. Effects of a 3-day low fat diet on metabolic control, insulin sensitivity, lipids and lipoprotein hormones in Norwegian subjects with hypertriacylglycerolemia and type 2 diabetes. Scand J Clin Lab Invest 2004; 64: 656574.
  • 31
    Arsov T, Carter CZ, Nolan CJ, Petrovsky N, Goodnow CC, Teoh NC, et al. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. Biochem Biophys Res Comm 2006; 342: 11521159.
  • 32
    Carmiel-Haggai M, Cederbaun, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 2005; 19: 136138.
  • 33
    Wang D, Wei Y, Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006; 147: 943951.
  • 34
    Lu L, Zeng M, Li J, Hua J, Fan J, Fan Z, et al. Effects of Kupffer cells stimulated by triglyceride and very low-density lipoprotein on proliferation of rat hepatic stellate cells. Chin Med 1999; 112: 325329.
  • 35
    Ikura Y, Ohsaka M, Fukushima M, Ryo Y, Muraguchi T. Increased expression of the scavenger receptor CD36 in activated stellate cells in steatotic livers; its relation to fibrotic process in non-alcoholic fatty liver disease. [Abstract] HEPATOLOGY 2005; 42(S1): 620A.
  • 36
    Pan M, Cederhaum AI, Zhang YL, Ginsberg HW, Williams KJ, Fisher FA. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 2004; 113: 12771287.
  • 37
    Liu LF, Purushotham A, Wendel AA, Belury MA. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1671G1682.